To assess the diagnostic performance and utility of the ExoDx IntelliScore and an OPKO4K score to predict prostate cancer in men presenting with elevated PSA—both as independent predictors and in combination with clinical/MRI characteristics. This evidence concerns the gene KLK3 and prostate cancer.